This article and associated images are based on a poster originally authored by Sophie O’Neil, Kyle Thompson, Rita Pereira, Emily Russell and Stuart McElroy and presented at ELRIG Drug Discovery 2025 ...
Serotonin, or 5-hydroxytryptamine (5-HT), is a ubiquitous neurotransmitter that exerts wide-ranging effects on the central nervous system (CNS) through activation of at least fourteen receptor ...
Fully non-hallucinogenic, oral, non-scheduled 5-HT2A neuroplastogen differentiates BETR-001 from every other 5-HT2A agonist program; depression and other psychiatric disorders retained as optional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results